Skip to main content
ImmuneCited

Vitamin D 用于 Immune Aging (Immunosenescence)

B

Research suggests vitamin D supplementation in elderly populations may help improve immune markers and vaccine response. Deficiency is highly prevalent in older adults and is associated with impaired immune function and increased infection susceptibility.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dimmunosenescence'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

结论

Research suggests vitamin D supplementation in elderly populations may help improve immune markers and vaccine response. Deficiency is highly prevalent in older adults and is associated with impaired immune function and increased infection susceptibility.

Key Study Findings

Review
Fanconi anaemia as a human model of accelerated epigenetic and immune ageing.
Dose: None vs: None Outcome: None 效果: None None

研究人群: patients with Fanconi anaemia

Randomized Controlled Trial n=124
Effects of a Novel Dispersible Supplement Containing 2500 IU of Vitamin D and 1000 µg …
Dose: 2500 IU vitamin D + 1000 mcg B12 vs: Separate D+B12 and no supplementation control Outcome: Serum 25-OH-D and B12 level restoration 效果: 37.1% adequate vs 29.4% separate None

研究人群: Adults with vitamin D (<20ng/mL) and B12 (<250ng/L) insufficiency

Observational Study n=72
Cardiovascular Risk and Systemic Inflammation in Alopecia Areata: An Observational Case-control Study.
Dose: None vs: Healthy controls Outcome: CVR and systemic inflammation in alopecia areata 效果: None None

研究人群: 36 AA patients vs 36 matched controls, mean age 39

Controlled Clinical Trial
Vitamin D stimulates Il-15 synthesis in rodent muscle.
Dose: Single dose (rats); variable (in vitro) vs: Untreated controls; VDR-KO mice Outcome: IL-15 gene expression in skeletal muscle 效果: None None

研究人群: C2C12 myotubes, rats, VDR-KO mice

Randomized Controlled Trial 8 weeks
Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus …
Dose: Topical ointment application (3 arms) vs: 3-arm: mometasone vs calcipotriol vs tacrolimus Outcome: SALT score change at 8 weeks 效果: None <0.001 (momet, calcipot)

研究人群: Patients with localized alopecia areata

Other
Modelling the influence of vitamin D and probiotics on inflammation and the intestinal microbiota in …
Dose: None vs: No supplementation (modeled) Outcome: Epithelial barrier integrity and immune response 效果: None None

研究人群: Older adults (mathematical model)

Key Statistics

10

研究数量

5000

受试者

Positive

B

等级

Referenced Papers

Biochemistry and biophysics … 2025
International journal of … 2023 54 次引用
Autoimmunity reviews 2023 24 次引用
Physiological research 2021 2 次引用
Advances in chronic … 2019 326 次引用
Actas dermo-sifiliograficas 2019 43 次引用
European journal of … 2017 66 次引用
Postepy dermatologii i … 2017 31 次引用
World journal of … 2016 238 次引用
Ageing research reviews 2016 142 次引用
Postepy dermatologii i … 2016 59 次引用
Indian dermatology online … 2016 51 次引用
World journal of … 2015 62 次引用
The American journal … 2014 125 次引用
European journal of … 2012 225 次引用
Inflammatory bowel diseases 2012 224 次引用
Gerontology 2011 27 次引用
Gastroenterology 2010 390 次引用
Artificial organs 2006 76 次引用
Aging cell 2004 102 次引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
600-800 IU/day
immunesupport:
1,000-2,000 IU/day
deficiencycorrection:
4,000-5,000 IU/day (under medical supervision)

上限: 4,000 IU/day (100 mcg)

研究中使用的剂量

剂量 持续时间 效果 N
None -- Negative --
2500 IU vitamin D + 1000 mcg B12 -- Positive 124
None -- Negative 72
Single dose (rats); variable (in vitro) -- Positive --
Topical ointment application (3 arms) 8 weeks Positive --
None -- Positive --
None -- Mixed --
None -- Mixed --

最佳服用时间: With a meal containing fat for better absorption

Safety & Side Effects

已报告的副作用

  • Hypercalcemia at very high doses (nausea, vomiting, weakness)
  • Kidney stones with excessive long-term use
  • Constipation
  • Metallic taste

已知相互作用

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)
  • Statins (vitamin D may affect statin metabolism)

可耐受最高摄入量: 4,000 IU/day (100 mcg)

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does Vitamin D help with Immune Aging (Immunosenescence)?
Based on 10 studies with 5,000 participants, there is moderate evidence from clinical studies that Vitamin D may support Immune Aging (Immunosenescence) management. Our evidence grade is B (Good Evidence).
How much Vitamin D should I take for Immune Aging (Immunosenescence)?
Studies have used various dosages. A commonly studied range is 600-800 IU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones with excessive long-term use, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Immune Aging (Immunosenescence)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 5,000 total participants. The overall direction of effect is positive.

Related Evidence

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。